Article Text

Download PDFPDF
Ultraradical surgery for advanced carcinoma of the vulva: an update
  1. M. S. Hoffman,
  2. D. Cavanagh,
  3. W. S. Roberts,
  4. J. V. Fiorica and
  5. M. A. Finan
  1. Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Tampa General Hospital and the H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa, Florida, USA
  1. Address for correspondence: Mitchel S. Hoffman, MD, H. Lee Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Florida 336129497, USA.


From July 1, 1955 to March 31, 1989 24 patients with locally advanced vulvar cancer underwent ultraradical resection. Three patients had received prior radiotherapy. Seventeen of the 24 patients underwent posterior exenteration, four underwent anterior exenteration, and the remaining three required a total pelvic exenteration. One patient died 3 months postoperatively of fulminating infection considered to be a complication of the operation. Three other patients experienced serious complications, including postoperative hemorrhage, severe urinary sepsis, and colostomy stoma necrosis. Eleven (46%) of the 24 patients have remained alive without evidence of recurrent cancer for at least 3 years. Of the 10 patients known to have died of recurrent cancer, nine had positive lymph nodes at the time of surgery. It may be reasonable to utilize ultraradical surgery in patients with clearly resectable lesions who have negative or perhaps 1 or 2 microscopically positive regional lymph nodes.

  • advanced
  • ultraradical surgery
  • vulvar cancer.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.